The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACELYRIN INC | COM | 00445A100 | BBG00YJKJ8H4 | 4,824,718 | 714,773 | SH | SOLE | 642,632 | 72,141 | 0 | 0 | |
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 00449L102 | BBG00ZHF9VV8 | 1,732,188 | 1,385,750 | SH | SOLE | 1,066,783 | 318,967 | 0 | 0 | |
AMICUS THERAPEUTICS INC | COM | 03152W109 | BBG000PLF6N0 | 18,225,321 | 1,547,141 | SH | SOLE | 1,149,802 | 397,339 | 0 | 0 | |
AMICUS THERAPEUTICS INC | COM | 03152W109 | BBG01HY4TXV7 | 120,000 | 400,000 | SH | Call | SOLE | 400,000 | 0 | 0 | 0 |
ANAPTYSBIO INC | COM | 032724106 | BBG0026ZDHR0 | 6,070,221 | 269,548 | SH | SOLE | 269,548 | 0 | 0 | 0 | |
ANNEXON INC | COM | 03589W102 | BBG007QVDFG2 | 4,338,689 | 605,117 | SH | SOLE | 605,117 | 0 | 0 | 0 | |
APPLIED THERAPEUTICS INC | COM | 03828A101 | BBG000DD0489 | 13,715,709 | 2,017,016 | SH | SOLE | 1,628,005 | 389,011 | 0 | 0 | |
ARCELLX INC | COMMON STOCK | 03940C100 | BBG01LH219C5 | 135,000 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | 0 |
ARCELLX INC | COMMON STOCK | 03940C100 | BBG00QHJM4S9 | 9,755,570 | 140,267 | SH | SOLE | 140,267 | 0 | 0 | 0 | |
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | BBG00QN8K4M4 | 21,860,459 | 2,205,899 | SH | SOLE | 1,940,482 | 265,417 | 0 | 0 | |
ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | BBG01LH5LJK5 | 515,625 | 825,000 | SH | Put | SOLE | 825,000 | 0 | 0 | 0 |
ASTRIA THERAPEUTICS INC | COM | 04635X102 | BBG000QSGWX5 | 2,676,878 | 230,273 | SH | SOLE | 230,273 | 0 | 0 | 0 | |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | BBG00KVT05R6 | 18,921,300 | 2,965,721 | SH | SOLE | 2,244,620 | 721,101 | 0 | 0 | |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | BBG01LH6G253 | 68,750 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | 0 |
AVADEL PHARMACEUTICALS PLC | COM | G29687103 | BBG00FPFX9W4 | 3,777,617 | 223,660 | SH | SOLE | 223,660 | 0 | 0 | 0 | |
AVIDITY BIOSCIENCES INC | COM | 05370A108 | BBG01LJJHPT5 | 183,750 | 75,000 | SH | Call | SOLE | 75,000 | 0 | 0 | 0 |
BIOHAVEN LTD | COM | G1110E107 | BBG01KDZ68N3 | 121,500 | 30,000 | SH | Put | SOLE | 30,000 | 0 | 0 | 0 |
BIOHAVEN LTD | COM | G1110E107 | BBG017BXV3Q9 | 4,564,482 | 83,461 | SH | SOLE | 83,461 | 0 | 0 | 0 | |
CABALETTA BIO INC | COM | 12674W109 | BBG00MJ3BKW2 | 17,126,807 | 1,003,916 | SH | SOLE | 759,352 | 244,564 | 0 | 0 | |
CABALETTA BIO INC | COM | 12674W109 | BBG01LHBVD42 | 1,075,000 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | 0 |
CARGO THERAPEUTICS INC | COM | 14179K101 | BBG01D59LY25 | 1,141,132 | 51,126 | SH | SOLE | 51,126 | 0 | 0 | 0 | |
CG ONCOLOGY INC | COM | 156944100 | BBG00YHKK4Q3 | 1,787,740 | 40,723 | SH | SOLE | 40,723 | 0 | 0 | 0 | |
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | BBG00BC59224 | 29,012,323 | 619,789 | SH | SOLE | 511,120 | 108,669 | 0 | 0 | |
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | BBG01L794MR3 | 157,500 | 175,000 | SH | Put | SOLE | 175,000 | 0 | 0 | 0 |
DIANTHUS THERAPEUTICS INC | COM | 252828108 | BBG00FB2NPZ0 | 1,303,680 | 43,456 | SH | SOLE | 43,456 | 0 | 0 | 0 | |
DISC MEDICINE INC | COM | 254604101 | BBG00W9MJK79 | 3,743,632 | 60,129 | SH | SOLE | 60,129 | 0 | 0 | 0 | |
EFFECTOR THERAPEUTICS INC | COM NEW | 28202V207 | BBG00YMWT4N5 | 1,910,891 | 132,793 | SH | SOLE | 99,478 | 33,315 | 0 | 0 | |
ELI LILLY & CO | COM | 532457108 | BBG000BNBDC2 | 11,721,523 | 15,067 | SH | SOLE | 15,067 | 0 | 0 | 0 | |
FULCRUM THERAPEUTICS INC | COM | 359616109 | BBG00DDY1RK9 | 3,843,100 | 407,108 | SH | SOLE | 407,108 | 0 | 0 | 0 | |
HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | BBG01L3GYF02 | 2,080,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | 0 | |
IDEAYA BIOSCIENCES INC | COM | 45166A102 | BBG00CTZ4D83 | 3,834,805 | 87,393 | SH | SOLE | 87,393 | 0 | 0 | 0 | |
IMMATICS N.V | SHS | N44445109 | BBG00VTL2H76 | 5,170,142 | 491,926 | SH | SOLE | 491,926 | 0 | 0 | 0 | |
IMMUNOVANT INC | COM | 45258J102 | BBG00P5MC0Q8 | 20,265,737 | 627,228 | SH | SOLE | 467,262 | 159,966 | 0 | 0 | |
IMMUNOVANT INC | COM | 45258J102 | BBG01HZYTN42 | 318,750 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | 0 |
INSMED INC | COM PAR $.01 | 457669307 | BBG000BWM5P3 | 7,391,514 | 272,448 | SH | SOLE | 227,378 | 45,070 | 0 | 0 | |
JANUX THERAPEUTICS INC | COM | 47103J105 | BBG00ZHSKH11 | 4,579,821 | 121,642 | SH | SOLE | 121,642 | 0 | 0 | 0 | |
JASPER THERAPEUTICS INC | COM NEW | 471871202 | BBG00QPZNP97 | 3,793,635 | 129,211 | SH | SOLE | 110,284 | 18,927 | 0 | 0 | |
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | BBG0026ZG5B0 | 13,770,172 | 1,161,060 | SH | SOLE | 790,666 | 370,394 | 0 | 0 | |
KRYSTAL BIOTECH INC | COM | 501147102 | BBG01LQH1665 | 71,000 | 20,000 | SH | Put | SOLE | 20,000 | 0 | 0 | 0 |
KYVERNA THERAPEUTICS INC | COM | 501976104 | BBG00RCYMHR1 | 1,018,440 | 41,000 | SH | SOLE | 41,000 | 0 | 0 | 0 | |
LARIMAR THERAPEUTICS INC | COM | 517125100 | BBG001J2NVH0 | 5,623,256 | 740,877 | SH | SOLE | 646,337 | 94,540 | 0 | 0 | |
MERUS N V | COM | N5749R100 | BBG01LJ7RT12 | 212,500 | 85,000 | SH | Put | SOLE | 85,000 | 0 | 0 | 0 |
MERUS N V | COM | N5749R100 | BBG00B8LXMS5 | 10,531,211 | 233,871 | SH | SOLE | 233,871 | 0 | 0 | 0 | |
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | BBG00XQZQTS9 | 4,553,199 | 90,647 | SH | SOLE | 90,647 | 0 | 0 | 0 | |
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | BBG01BNNTQN4 | 1,899,899 | 80,334 | SH | SOLE | 80,334 | 0 | 0 | 0 | |
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | BBG00W9LF2G5 | 1,641,011 | 26,893 | SH | SOLE | 26,893 | 0 | 0 | 0 | |
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | BBG01LJQQYP4 | 13,185 | 87,900 | SH | Call | SOLE | 87,900 | 0 | 0 | 0 |
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | BBG001ZLYSH5 | 675,452 | 168,442 | SH | SOLE | 168,442 | 0 | 0 | 0 | |
PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | BBG00PQFFCV5 | 7,643,271 | 1,794,195 | SH | SOLE | 1,531,924 | 262,271 | 0 | 0 | |
ROIVANT SCIENCES LTD | SHS | G76279101 | BBG01LJJMMG0 | 56,250 | 750,000 | SH | Put | SOLE | 750,000 | 0 | 0 | 0 |
ROIVANT SCIENCES LTD | SHS | G76279101 | BBG007STW2B8 | 37,457,516 | 3,553,844 | SH | SOLE | 3,553,844 | 0 | 0 | 0 | |
SOLENO THERAPEUTICS INC | COM | 834203309 | BBG0024L5B86 | 4,957,652 | 115,833 | SH | SOLE | 115,833 | 0 | 0 | 0 | |
SPDR SER TR | S&P BIOTECH | 78464A870 | BBG01LNQ9H48 | 876,000 | 1,200,000 | SH | Put | SOLE | 1,200,000 | 0 | 0 | 0 |
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | BBG0067L94B2 | 2,361,256 | 62,253 | SH | SOLE | 62,253 | 0 | 0 | 0 | |
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG000R33JY1 | 26,203,514 | 1,100,988 | SH | SOLE | 1,100,988 | 0 | 0 | 0 | |
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | BBG01HZ3CR49 | 41,250 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | 0 |
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | BBG00RB9BNQ7 | 8,078,897 | 222,253 | SH | SOLE | 222,253 | 0 | 0 | 0 | |
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | BBG00TJXFDP1 | 3,121,943 | 1,087,785 | SH | SOLE | 1,087,785 | 0 | 0 | 0 | |
TOURMALINE BIO INC | COM | 89157D105 | BBG00NX995R3 | 6,279,615 | 274,219 | SH | SOLE | 199,401 | 74,818 | 0 | 0 | |
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | BBG01LJW51T2 | 10,750 | 10,000 | SH | Call | SOLE | 10,000 | 0 | 0 | 0 |
VERA THERAPEUTICS INC | CL A | 92337R101 | BBG01LJWQ8P8 | 75,000 | 40,000 | SH | Put | SOLE | 40,000 | 0 | 0 | 0 |
VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 2,787,999 | 616,749 | SH | SOLE | 616,749 | 0 | 0 | 0 | |
VISTAGEN THERAPEUTICS INC | COM | 92840H400 | BBG000BB33L9 | 6,504,078 | 1,231,833 | SH | SOLE | 976,679 | 255,154 | 0 | 0 |